Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 5/2008

Content (12 Articles)

Original Paper

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

Xueling Ou, Shaohui Cai, Peng Liu, Jun Zeng, Yuwen He, Xinyao Wu, Jun Du

Original Paper

Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma

Hui Wang, Ke Pan, Hua-kun Zhang, De-sheng Weng, Jun Zhou, Jian-jun Li, Wei Huang, Hai-feng Song, Min-shan Chen, Jian-chuan Xia

Original Paper

Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value

Carsten Kempkensteffen, Stefan Hinz, Frank Christoph, Hans Krause, Ahmed Magheli, Mark Schrader, Martin Schostak, Kurt Miller, Steffen Weikert

Original Paper

Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells

Mikio Tomida, Hideki Ohtake, Takashi Yokota, Yasuhito Kobayashi, Masafumi Kurosumi

Original Paper

Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers

Yasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, Nariaki Matsuura, Masato Takahashi, Eriko Tokunaga, Chiyomi Egawa, Norikazu Masuda, Seung Jin Kim, Masatsugu Okishiro, Tetsu Yanagisawa, Satsuki Ueda, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi

Original Paper

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

Hidefumi Sasaki, Katsuhiko Endo, Katsuhiro Okuda, Osamu Kawano, Naoto Kitahara, Hisaichi Tanaka, Akihide Matsumura, Keiji Iuchi, Minoru Takada, Masaaki Kawahara, Tomoya Kawaguchi, Haruhiro Yukiue, Tomoki Yokoyama, Motoki Yano, Yoshitaka Fujii

Open Access Original Paper

APC promoter methylation and protein expression in hepatocellular carcinoma

Antal Csepregi, Christoph Röcken, Juliane Hoffmann, Ping Gu, Stephan Saliger, Oliver Müller, Regine Schneider-Stock, Nadine Kutzner, Albert Roessner, Peter Malfertheiner, Matthias P. A. Ebert

Original Paper

Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk

Guenter Hofmann, Uwe Langsenlehner, Wilfried Renner, Tanja Langsenlehner, Babak Yazdani-Biuki, Heimo Clar, Armin Gerger, Martin Wehrschuetz, Hellmut Samonigg, Peter Krippl

Original Paper

Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice

Martina Hubensack, Christine Müller, Peter Höcherl, Stephan Fellner, Thilo Spruss, Günther Bernhardt, Armin Buschauer

Original Paper

Overexpression of cFLIP in head and neck squamous cell carcinoma and its clinicopathologic correlations

Xiuguo Li, Xinliang Pan, Hui Zhang, Dapeng Lei, Dayu Liu, Fenglei Xu, Xinyong Luan

Original Paper

Familial risk for soft tissue tumors: a nation-wide epidemiological study from Sweden

Jianguang Ji, Charis Eng, Kari Hemminki

Rapid Communication

Surgical debulking of gastrointestinal stromal tumors: Is it a reasonable option after second-line treatment with sunitinib?

M. A. Pantaleo, M. Di Battista, F. Catena, M. Astorino, M. Saponara, V. Di Scioscio, D. Santini, G. Piazzi, P. Castellucci, G. Brandi, G. Biasco

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine